Dr Dave Coman
Dr

Dave Coman

Email: 

Background

David is a Consultant Paediatrician, Metabolic Physician, Clinical Geneticist and clinician researcher. His area of expertise is the diagnosis and management of children with rare diseases. David is involved in multiple ongoing research projects aimed at novel disease discovery, improved diagnostic testing and treatments for children with inherited genetic disorders. He is director of a national clinic for Ataxia Telangiectasia brashat.org.au and has recently been awarded a $2.5 million NHMRC research grant for a phase 2/3 trial for treatment of this disorder.

Availability

Dr Dave Coman is:
Available for supervision

Fields of research

Biological Sciences Biomedical and Clinical Sciences Clinical sciences Developmental genetics (incl. sex determination) Gene expression (incl. microarray and other genome-wide approaches) Genetics Genomics Medical biochemistry - amino acids and metabolites Medical biochemistry and metabolomics Medical genetics (excl. cancer genetics) Metabolic medicine Paediatrics

Qualifications

  • Australian Health Practitioner Regulation Agency, Australian Health Practitioner Regulation Agency
  • Australian Medical Association, Australian Medical Association
  • Human Genetics Society of Australasia, Human Genetics Society of Australasia
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • Society for the Study of Inborn Errors of Metabolism, Society for the Study of Inborn Errors of Metabolism

Research impacts

David has close relationships with research colleagues both in Australia and internationally. He has multiple ongoing research projects investigating novel disease identification, the genetics of paediatric speech disorders and the development of new therapeutic possibilities for children and adults with rare diseases.

Search Professor Dave Coman’s works on UQ eSpace

132 works between 2005 and 2025
All (132) Journal Article (115) Conference Publication (11) Book Chapter (6)

61 - 80 of 132 works

2018

Journal Article

Tread carefully: a functional variant in the human NADPH oxidase 4 (NOX4) is not disease causing

Nafisinia, Michael, Menezes, Minal Juliet, Gold, Wendy Anne, Riley, Lisa, Hatch, Joshua, Cardinal, John, Coman, David and Christodoulou, John (2018). Tread carefully: a functional variant in the human NADPH oxidase 4 (NOX4) is not disease causing. Molecular Genetics and Metabolism, 123 (3), 382-387. doi: 10.1016/j.ymgme.2018.01.007

Tread carefully: a functional variant in the human NADPH oxidase 4 (NOX4) is not disease causing

2018

Journal Article

Transient neonatal zinc deficiency in exclusively breastfed preterm infants

Watson, Lauren, Cartwright, David, Jardine, Luke A, Pincus, David, Koorts, Pieter, Kury, Sebastien, Bezieau, Stephanie, George, Shane, Moloney, Susan, Holt, Johanna and Coman, David (2018). Transient neonatal zinc deficiency in exclusively breastfed preterm infants. Journal of Paediatrics and Child Health, 54 (3), 319-322. doi: 10.1111/jpc.13780

Transient neonatal zinc deficiency in exclusively breastfed preterm infants

2018

Journal Article

Keeping an eye on congenital disorders of O-glycosylation: a systematic literature review

Francisco, R., Pascoal, C., Marques-da-Silva, D., Morava, E., Gole, G. A., Coman, D., Jaeken, J. and Dos Reis Ferreira, Vanessa (2018). Keeping an eye on congenital disorders of O-glycosylation: a systematic literature review. Journal of Inherited Metabolic Disease, 1-16. doi: 10.1007/s10545-017-0119-2

Keeping an eye on congenital disorders of O-glycosylation: a systematic literature review

2017

Journal Article

Leber Hereditary Optic Neuropathy and Longitudinally Extensive Transverse Myelitis

Bursle, C., Riney, K., Stringer, J., Moore, D., Gole, G., Kearns, L. S., Mackey, D. A. and Coman, D. (2017). Leber Hereditary Optic Neuropathy and Longitudinally Extensive Transverse Myelitis. JIMD Reports, 42, 53-60. doi: 10.1007/8904_2017_79

Leber Hereditary Optic Neuropathy and Longitudinally Extensive Transverse Myelitis

2017

Journal Article

An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants

Pop, Ana, Williams, Monique, Struys, Eduard A., Monné, Magnus, Jansen, Erwin E. W., De Grassi, Anna, Kanhai, Warsha A., Scarcia, Pasquale, Ojeda, Matilde R. Fernandez, Porcelli, Vito, van Dooren, Silvy J. M., Lennertz, Pascal, Nota, Benjamin, Abdenur, Jose E., Coman, David, Das, Anibh Martin, El-Gharbawy, Areeg, Nuoffer, Jean-Marc, Polic, Branka, Santer, René, Weinhold, Natalie, Zuccarelli, Britton, Palmieri, Ferdinando, Palmieri, Luigi and Salomons, Gajja S. (2017). An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants. Journal of Inherited Metabolic Disease, 41 (2), 169-180. doi: 10.1007/s10545-017-0106-7

An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants

2017

Journal Article

Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation

Bursle, C, Weintraub, R, Ward, C, Justo, R, Cardinal, J and Coman, D (2017). Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation. JIMD reports, 40, 91-95. doi: 10.1007/8904_2017_68

Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation

2017

Journal Article

X-Linked Lissencephaly With Absent Corpus Callosum and Abnormal Genitalia: An Evolving Multisystem Syndrome With Severe Congenital Intestinal Diarrhea Disease

Coman, David, Fullston, Tom, Shoubridge, Cheryl, Leventer, Richard, Wong, Flora, Nazaretian, Simon, Simpson, Ian, Gecz, Josef and McGillivray, George (2017). X-Linked Lissencephaly With Absent Corpus Callosum and Abnormal Genitalia: An Evolving Multisystem Syndrome With Severe Congenital Intestinal Diarrhea Disease. Child Neurology Open, 4, 1-6. doi: 10.1177/2329048X17738625

X-Linked Lissencephaly With Absent Corpus Callosum and Abnormal Genitalia: An Evolving Multisystem Syndrome With Severe Congenital Intestinal Diarrhea Disease

2017

Journal Article

GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS

Waak, Michaela, Mohammad, Shekeeb S., Coman, David, Sinclair, Kate, Copeland, Lisa, Silburn, Peter, Coyne, Terry, McGill, Jim, O'Regan, Mary, Selway, Richard, Symonds, Joseph, Grattan-Smith, Padraic, Lin, Jean-Pierre, Dale, Russell C. and Malone, Stephen (2017). GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS. Journal of Neurology, Neurosurgery and Psychiatry, 89 (2), 220-+. doi: 10.1136/jnnp-2017-315653

GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS

2017

Journal Article

Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions

Guitart, Amelie V., Panagopoulou, Theano I., Villacreces, Arnaud, Vukovic, Milica, Sepulveda, Catarina, Allen, Lewis, Carter, Roderick N., van de Lagemaat, Louie N., Morgan, Marcos, Giles, Peter, Sas, Zuzanna, Gonzalez, Marta Vila, Lawson, Hannah, Paris, Jasmin, Edwards-Hicks, Joy, Schaak, Katrin, Subramani, Chithra, Gezer, Deniz, Armesilla-Diaz, Alejandro, Wills, Jimi, Easterbrook, Aaron, Coman, David, So, Chi Wai Eric, O'Carroll, Donal, Vernimmen, Douglas, Rodrigues, Neil P., Pollard, Patrick J., Morton, Nicholas M., Finch, Andrew and Kranc, Kamil R. (2017). Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions. The Journal of Experimental Medicine, 214 (3), 719-735. doi: 10.1084/jem.20161087

Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions

2017

Book Chapter

DMP1-CDG (CDG1e) with significant gastrointestinal manifestations; phenotype and genotype expansion

Bursle, Carolyn, Brown, Dominique, Cardinal, John, Connor, Frances, Calvert, Sophie and Coman, David (2017). DMP1-CDG (CDG1e) with significant gastrointestinal manifestations; phenotype and genotype expansion. JIMD Reports. (pp. 27-32) Berlin, Germany: Springer. doi: 10.1007/8904_2016_7

DMP1-CDG (CDG1e) with significant gastrointestinal manifestations; phenotype and genotype expansion

2017

Book Chapter

COXPD9 an evolving multisystem disease; congenital lactic acidosis, sensorineural hearing loss, hypertrophic cardiomyopathy, cirrhosis and interstitial nephritis

Bursle, Carolyn, Narendra, Anna, Chuk, Raymond, Cardinal, John, Justo, Rob, Lewis, Bruce and Coman, David (2017). COXPD9 an evolving multisystem disease; congenital lactic acidosis, sensorineural hearing loss, hypertrophic cardiomyopathy, cirrhosis and interstitial nephritis. JIMD Reports. (pp. 105-109) edited by Eva Morava, Matthias Baumgartner, Marc Patterson, Shamima Rahman, Johannes Zschocke and Verena Peters. Berlin, Heidelberg: Springer. doi: 10.1007/8904_2016_13

COXPD9 an evolving multisystem disease; congenital lactic acidosis, sensorineural hearing loss, hypertrophic cardiomyopathy, cirrhosis and interstitial nephritis

2016

Journal Article

Persistent Hyperinsulinism in Kabuki Syndrome 2: Case Report and Literature Review

Gole, Hobia, Chuk, Raymond and Coman, David (2016). Persistent Hyperinsulinism in Kabuki Syndrome 2: Case Report and Literature Review. Clinics and Practice, 6 (3) 848, 1-3. doi: 10.4081/cp.2016.848

Persistent Hyperinsulinism in Kabuki Syndrome 2: Case Report and Literature Review

2016

Journal Article

De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies

Myers, Candace T., McMahon, Jacinta M., Schneider, Amy L., Petrovski, Slavé, Allen, Andrew S., Carvill, Gemma L., Zemel, Matthew, Saykally, Julia E., LaCroix, Amy J., Heinzen, Erin L., Hollingsworth, Georgina, Nikanorova, Marina, Corbett, Mark, Gecz, Jozef, Coman, David, Freeman, Jeremy, Calvert, Sophie, Gill, Deepak, Carney, Patrick, Lerman-Sagie, Tally, Sampaio, Hugo, Cossette, Patrick, Delanty, Norman, Dlugos, Dennis, Eichler, Evan E., Epstein, Michael P., Glauser, Tracy, Johnson, Michael R., Kuzniecky, Ruben ... Epi4K Consortium (2016). De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies. American Journal of Human Genetics, 99 (2), 287-298. doi: 10.1016/j.ajhg.2016.06.003

De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies

2016

Journal Article

Erratum to: Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey

Briggs, Tracy A., Rice, Gillian I., Adib, Navid, Ades, Lesley, Barete, Stephane, Baskar, Kannan, Baudouin, Veronique, Cebeci, Ayse N., Clapuyt, Philippe, Coman, David, De Somer, Lien, Finezilber, Yael, Frydman, Moshe, Guven, Ayla, Heritier, Sébastien, Karall, Daniela, Kulkarni, Muralidhar L., Lebon, Pierre, Levitt, David, Le Merrer, Martine, Linglart, Agnes, Livingston, John H., Navarro, Vincent, Okenfuss, Ericka, Puel, Anne, Revencu, Nicole, Scholl-Bürgi, Sabine, Vivarelli, Marina, Wouters, Carine ... Crow, Yanick J. (2016). Erratum to: Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey. Journal of Clinical Immunology, 36 (5), 529-530. doi: 10.1007/s10875-016-0287-0

Erratum to: Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey

2016

Journal Article

Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey

Briggs, Tracy A., Rice, Gillian I., Adib, Navid, Ades, Lesley, Barete, Stephane, Baskar, Kannan, Baudouin, Veronique, Cebeci, Ayse N., Clapuyt, Philippe, Coman, David, De Somer, Lien, Finezilber, Yael, Frydman, Moshe, Guven, Ayla, Heritier, Sébastien, Karall, Daniela, Kulkarni, Muralidhar L., Lebon, Pierre, Levitt, David, Le Merrer, Martine, Linglart, Agnes, Livingston, John H., Navarro, Vincent, Okenfuss, Ericka, Puel, Anne, Revencu, Nicole, Scholl-Bürgi, Sabine, Vivarelli, Marina, Wouters, Carine ... Crow, Yanick J. (2016). Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey. Journal of Clinical Immunology, 36 (3), 220-234. doi: 10.1007/s10875-016-0252-y

Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey

2016

Journal Article

Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations

Lalani, Seema R., Liu, Pengfei, Rosenfeld, Jill A., Watkin, Levi B., Chiang, Theodore, Leduc, Magalie S., Zhu, Wenmiao, Ding, Yan, Pan, Shujuan, Vetrini, Francesco, Miyake, Christina Y., Shinawi, Marwan, Gambin, Tomasz, Eldomery, Mohammad K., Akdemir, Zeynep Hande Coban, Emrick, Lisa, Wilnai, Yael, Schelley, Susan, Koenig, Mary Kay, Memon, Nada, Farach, Laura S., Coe, Bradley P., Azamian, Mahshid, Hernandez, Patricia, Zapata, Gladys, Jhangiani, Shalini N., Muzny, Donna M., Lotze, Timothy, Clark, Gary ... Yang, Yaping (2016). Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations. American Journal of Human Genetics, 98 (2), 347-357. doi: 10.1016/j.ajhg.2015.12.008

Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations

2016

Journal Article

De Novo 3q22.3q24 Microdeletion in a Patient With Blepharophimosis–Ptosis–Epicanthus Inversus Syndrome, Dandy-Walker Malformation, and Wisconsin Syndrome

Ramineni, Anand and Coman, David (2016). De Novo 3q22.3q24 Microdeletion in a Patient With Blepharophimosis–Ptosis–Epicanthus Inversus Syndrome, Dandy-Walker Malformation, and Wisconsin Syndrome. Child Neurology Open, 3, 1-6. doi: 10.1177/2329048x16666362

De Novo 3q22.3q24 Microdeletion in a Patient With Blepharophimosis–Ptosis–Epicanthus Inversus Syndrome, Dandy-Walker Malformation, and Wisconsin Syndrome

2016

Journal Article

<i>Arabidopsis</i> GERANYLGERANYL DIPHOSPHATE SYNTHASE 11 is a hub isozyme required for the production of most photosynthesis-related isoprenoids

Ruiz-Sola, M. Aguila, Coman, Diana, Beck, Gilles, Barja, M. Victoria, Colinas, Maite, Graf, Alexander, Welsch, Ralf, Ruetimann, Philipp, Buehlmann, Peter, Bigler, Laurent, Gruissem, Wilhelm, Rodriguez-Concepcion, Manuel and Vranova, Eva (2016). Arabidopsis GERANYLGERANYL DIPHOSPHATE SYNTHASE 11 is a hub isozyme required for the production of most photosynthesis-related isoprenoids. New Phytologist, 209 (1), 252-264. doi: 10.1111/nph.13580

<i>Arabidopsis</i> GERANYLGERANYL DIPHOSPHATE SYNTHASE 11 is a hub isozyme required for the production of most photosynthesis-related isoprenoids

2016

Journal Article

PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?

Coman, D., Lewindon, P., Clayton, P. and Riney, K. (2016). PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?. JIMD Reports, 25, 71-75. doi: 10.1007/8904_2015_456

PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?

2016

Journal Article

Pediatric Hereditary Neuralgic Amyotrophy : Successful Treatment With Intravenous Immunoglobulin and Insights Into SEPT9 Pathogenesis

Chuk, Raymond, Sheppard, Megan, Wallace, Geoff and Coman, David (2016). Pediatric Hereditary Neuralgic Amyotrophy : Successful Treatment With Intravenous Immunoglobulin and Insights Into SEPT9 Pathogenesis. Child Neurology Open, 3 2329048X1666897, 1-3. doi: 10.1177/2329048x16668970

Pediatric Hereditary Neuralgic Amyotrophy : Successful Treatment With Intravenous Immunoglobulin and Insights Into SEPT9 Pathogenesis

Current funding

  • 2024 - 2027
    Metabolic Medicine Research Clinical Trial in Ataxia-Telangiectasia
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2023 - 2028
    Introducing Mitochondrial Donation into Australia: The mitoHOPE (Healthy Outcomes Pilot and Evaluation) Program (MRFF EPCDRI grant led by Monash)
    Monash University
    Open grant
  • 2023 - 2028
    Translational Centre for Speech Disorders (NHMRC Centre of Research Excellence administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant

Past funding

  • 2021 - 2024
    Repairing catalase function in A-T patients using a CAT-SKL therapeutic
    National Stem Cell Foundation of Australia Matched Funding Program
    Open grant
  • 2020 - 2023
    A Phase 2A/2B placebo-controlled randomised clinical trial to test the ability of triheptanoin to protect primary airway epithelial cells obtained from patients with ataxia-telangiectasia against....
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2020 - 2022
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    Wesley Medical Research Ltd
    Open grant
  • 2020 - 2025
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2011 - 2013
    Early prediction of intellectual and cognitive-linguistic outcomes in children with treated galactosaemia
    APEX Foundation for Research into Intellectual Disability Ltd (AFRID)
    Open grant

Availability

Dr Dave Coman is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Enquiries

For media enquiries about Dr Dave Coman's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au